Levofloxacin Dosing for Ochrobactrum anthropi Infection
For adult patients with normal renal function (CrCl ≥50 mL/min), administer levofloxacin 500–750 mg orally or intravenously once daily for 7–14 days, with dose adjustments required for renal impairment. 1, 2
Standard Dosing in Adults with Normal Renal Function
- 500 mg once daily is the standard dose for most O. anthropi infections, given the organism's high susceptibility to levofloxacin (100% susceptibility in clinical series). 2
- 750 mg once daily may be considered for severe infections or sepsis to optimize peak concentration-dependent killing, particularly in critically ill patients. 3, 4
- Duration should be 7–14 days depending on infection severity and clinical response; bloodstream infections typically require 10–14 days. 2
- Levofloxacin can be administered without regard to food, and both oral and intravenous formulations achieve equivalent bioavailability (approaching 100%). 1, 5
Renal Dose Adjustments
Moderate Renal Impairment (CrCl 20–49 mL/min)
- Loading dose: 500 mg, followed by 250 mg once daily. 6, 1
- This regimen prevents drug accumulation while maintaining therapeutic concentrations. 6
Severe Renal Impairment (CrCl 10–19 mL/min)
- Loading dose: 500 mg, followed by 250 mg every 48 hours. 6, 1
- The extended interval compensates for the markedly prolonged elimination half-life (up to 34 hours in end-stage renal disease). 7
End-Stage Renal Disease on Hemodialysis
- Loading dose: 500 mg immediately after the first dialysis session. 6, 7
- Maintenance: 250 mg every 48 hours, administered immediately after each dialysis session (for thrice-weekly dialysis). 6, 7
- Never administer before or during hemodialysis, as approximately 24% of the drug is removed during each session, leading to subtherapeutic levels. 6, 7
- Supplemental post-dialysis dosing is not required beyond the scheduled maintenance dose. 1
Peritoneal Dialysis
- Use the hemodialysis regimen (500 mg loading, then 250 mg every 48 hours) and adjust based on clinical response and therapeutic drug monitoring if available. 6
- Evidence for peritoneal dialysis dosing is limited, requiring careful clinical monitoring. 6
Pharmacodynamic Considerations for O. anthropi
- O. anthropi demonstrates 100% susceptibility to levofloxacin in published case series, with MIC values typically ≤1 mg/L. 2
- Target pharmacodynamic parameters for optimal bactericidal activity: AUC₂₄/MIC ≥125 and Cmax/MIC ≥10 for Gram-negative organisms. 6
- The standard 500 mg daily dose achieves peak concentrations of 5.2–7.5 mg/L, providing Cmax/MIC ratios >5 for organisms with MIC ≤1 mg/L. 5, 8
- For critically ill patients, higher doses (750 mg daily) optimize concentration-dependent killing and account for increased volume of distribution from fluid resuscitation. 3, 4, 8
Clinical Context and Treatment Duration
- O. anthropi bloodstream infections typically occur in patients with indwelling catheters or foreign bodies, and catheter removal is essential for recurrent infections. 2
- Most infections are hospital-acquired (64% in one series) and may present with fever and altered mental status. 2
- The organism is widely resistant to penicillins and cephalosporins but highly susceptible to fluoroquinolones (levofloxacin, ciprofloxacin) and carbapenems (imipenem). 2
- Monotherapy with levofloxacin is appropriate for most O. anthropi infections given its excellent susceptibility profile; combination therapy is not routinely required. 2
Important Caveats
- Drug interactions: Administer levofloxacin at least 2 hours before or after antacids containing magnesium/aluminum, sucralfate, iron supplements, or multivitamins with zinc to avoid significantly decreased absorption. 1, 5
- Therapeutic drug monitoring should be considered in patients with end-stage renal disease to ensure adequate exposure while preventing accumulation. 6
- Adequate hydration should be maintained to prevent crystalluria, though this is rare with levofloxacin. 1
- For patients with severe renal dysfunction requiring dialysis, consultation with a nephrologist is advised for complex dosing scenarios. 9
- The loading dose (500 mg) is independent of renal function and should always be given to rapidly achieve therapeutic concentrations, particularly in severe infections. 6, 7